US IPO Analysis | FitLife International (FIT.US): B2B Sustains Short-Term Performance, Three Major Growth Paths Determine Long-Term Value
The increase in fundraising amount now meets Nasdaq's fundraising requirements for IPOs of China-related companies, marking another solid step forward in FitLife International's path to listing.
Since its founding in 2016, FitLife International, which has deep roots in the sports nutrition field, has completed a leapfrog expansion from Hong Kong to mainland China and Malaysia in just 10 years, accumulating the confidence to sprint toward the capital markets.
It was observed that on August 11, 2025, FitLife International submitted its first public version of the prospectus (F-1) to the SEC, officially launching the company's journey toward a U.S. listing. Since then, FitLife International has continued to update its listing materials, and on September 22 of this year, it was the company's fifth submission of an F-1/A filing.
According to the prospectus, in this IPO, FitLife International will issue 7 million ordinary shares at a price of US$4-6 per share, raising up to US$42 million. It is worth noting that in the first public version of the prospectus on August 11 last year, FitLife International only planned to issue 2 million ordinary shares at a price of US$4-5 per share, raising up to US$10 million.
The increase in fundraising this time has met Nasdaq's fundraising requirements for IPOs of China-related companies, meaning FitLife International has taken another solid step forward on its listing path.
In terms of performance, from 2023 to 2025, FitLife International's revenue was approximately US$11.8994 million, US$19.4613 million, and US$21.4111 million, respectively, achieving sustained growth; net profit during the same period was approximately -US$765,000, US$1.0197 million, and US$1.0278 million, respectively, with overall performance stable and improving.
B2B Becomes the Core Engine of Revenue Growth, B2C Business Under Phased Pressure
As a distributor of sports nutrition products with deep roots in the Hong Kong, Macau, and Southeast Asian markets, FitLife International does not have its own brand. The core of its business model is to purchase products from European and American brand owners and then distribute and sell them through an omni-channel network to earn price spreads and service revenue.
According to the prospectus, on the product side, as of the end of 2025, FitLife International distributed and sold sports nutrition products from more than 30 brands supplied by 12 brand owners and more than 10 distributors, with more than 300 SKUs. It is worth noting that FitLife International holds exclusive distribution rights for more than 160 SKUs in Hong Kong, while other SKUs distributed in Hong Kong and all SKUs in mainland China are distributed on a non-exclusive basis.
From the perspective of product categories, the products sold and distributed by FitLife International are divided into three major categories: protein powder, ready-to-eat snacks and packaged beverages, and other products including health supplements and special diets. Among them, protein powder, as the foundation, has consistently contributed more than 60% of revenue, while sports nutrition products as a whole accounted for as much as 94.6% of revenue in 2025.
In addition to selling sports nutrition products, FitLife International also uses its omni-channel sales and distribution network to provide auxiliary customized marketing services to sports nutrition brand owners and other distributors. In 2025, the company's marketing service revenue accounted for approximately 5.4%, a relatively small share of revenue.
In terms of channel and customer structure, FitLife International follows an omni-channel route with B2B and B2C running in parallel, and in recent years it has shown a clear trend toward B2B. Specifically, the B2B business mainly serves wholesalers, membership warehouse supermarkets, chain gyms, and retailers. As of the end of 2025, FitLife International had more than 130 B2B customers, reaching more than 1,300 points of sale (POS).
The B2C business directly reaches consumers through its own official website, the YOUZAN mall, third-party platforms (such as Tmall and HKTV Mall), and vending machines installed in gyms. By the end of 2025, the number of vending machines exceeded 360.
From a regional distribution perspective, Hong Kong remains the company's foundation, contributing 64.8% of revenue in 2025; mainland China, as the second-largest market, accounted for 34.0%, where the company avoided direct confrontation with low-priced local brands and instead relied on American-style membership warehouse chains and the Tmall platform to focus on imported high-end protein powder; the Malaysian market only started in May 2024 and currently accounts for only about 1% of revenue, serving more as a testing ground for Southeast Asian expansion.
In terms of performance, FitLife International's sustained rapid revenue growth was mainly driven by the accelerated volume ramp-up of the B2B business. According to the prospectus, from 2023 to 2025, the company's B2B business revenue was US$6.0328 million, US$11.4053 million, and US$14.1573 million, respectively, with a compound annual growth rate of as high as 53.19%, and its share of total revenue rose from approximately 50.70% in 2023 to approximately 66.1% in 2025, becoming the core engine driving revenue growth. The share of revenue from B2C fell from 49.30% in 2023 to 28.5%.
Along with sustained revenue growth, FitLife International's gross margin rose from 26.7% in 2024 to 31.7%, an increase of 5 percentage points, mainly because both the B2B and B2C businesses improved in both volume and price. Among them, B2B volume ramp-up diluted fulfillment costs and generated centralized procurement premiums, while B2C was supported by high-margin categories and direct-sales scenarios, thereby achieving simultaneous gross margin recovery on both sides. Driven by both revenue growth and gross margin improvement, FitLife International turned profitable in 2024, recording a profit of US$1.0197 million.
Entering 2025, although the B2B business drove the company's total revenue to continue growing, the increase in the share of this business naturally suppressed the consolidated gross margin, causing the gross margin during the reporting period to decline by 1.5 percentage points to 30.2%, which in turn suppressed the release of profit elasticity, with net profit of US$1.0278 million during the period, basically flat compared with 2024.
From this perspective, FitLife International's steady performance since 2023 is a phased result of the company actively adjusting resources and tilting its expansion focus toward the B2B channel, which has more stable collections and faster volume ramp-up. Although this puts short-term pressure on B2C, the overall performance is more stable, which may also be preparation for sprinting toward the IPO.
Three Growth Paths Outline the Future Development Blueprint, Overseas Expansion Opens Long-Term Imagination Space
After analyzing FitLife International's growth logic, the company's future development path is already very clear, with three growth curves at different rhythms jointly outlining the future growth blueprint. Among them, deeper densification of the B2B channel remains the most core DRIVE for performance release in the short to medium term.
In 2025, the share of FitLife International's B2B revenue had climbed to 66.1%. Future incremental growth does not rely on price increases, but rather on urban store densification of membership warehouse supermarkets (such as the two American-style wholesale warehouses in mainland China), continued binding with chain gym systems (Hong Kong has already partnered with one of the world's largest chains, and Malaysia is also rapidly rolling out), and extension into wholesale networks of sub-terminal outlets such as convenience stores and specialty stores to achieve outlet penetration. At the same time, if the amplification effect of more than 160 exclusive SKUs in the Hong Kong market can be further expanded into more categories through renewal with the largest supplier, there is still room for improvement in B2B pricing power and order density.
Compared with the B2B business, whose growth momentum is expected to continue, the B2C direct-sales business plays the role of "supporting profit" rather than "chasing volume." In 2025, the share of B2C revenue had shrunk to 28.5%, but the gross margin of this business rose against the trend to 48%. The key reason is that the company actively tilted resources toward high-premium direct-sales scenarios.
The B2C business's more than 360 vending machines embedded in gyms reach core fitness crowds, and the cross-border route through the Ningbo Bonded Zone (YOUZAN mall) enables direct sales of imported supplements, maintaining considerable purchase-sale price spreads under the policy dividend of exemption from VAT and consumption tax. The strategic significance of the B2C segment in the short term is not to reverse the downward trend in revenue share, but to use a gross margin of nearly 50% to keep the consolidated gross margin from continuing to decelerate, providing a profit buffer for the B2B volume ramp-up.
In addition to the purchase-sale price spread from product distribution, marketing services, as an asset-light curve for monetizing the channel network, are also worth watching. Although this business segment accounted for only 5.4% of revenue in 2025, its gross margin was as high as 68.5%. The high gross margin is because this business extends from "earning distribution spreads" to "earning brand owners' marketing budgets." As the total number of points of sale (POS) breaks through and continues to be replicated in emerging markets such as Malaysia, the value of channel exposure will gradually accumulate.
However, because brand owners currently have limited budgets and the company's own outlet scale has not yet reached a tipping point, the short-term contribution to overall revenue elasticity is relatively limited. Whether the value of this business can be accelerated and tapped is crucial to FitLife International's diversified monetization.
The new growth curve that truly opens up long-term market imagination is Malaysia and the broader Southeast Asian market. FitLife International only entered Malaysia in May 2024 and currently accounts for only about 1% of revenue, but the expansion path has been clearly laid out: the number of vending machines is targeted to exceed 100 by the end of 2026 from more than 70 in 2025, while the company plans to leverage existing gym chain partnerships to extend into B2B wholesale and third-party platform B2C businesses.
Malaysia's positioning is not just a testing ground, but also a springboard into Southeast Asian markets such as Singapore, Thailand, and Indonesia. The replicability of gym chains provides a standardized template for this expansion. If FitLife International can quickly open up the Malaysian market and verify the effectiveness of this model, it would undoubtedly prove to the market the feasibility of the company's expansion into Southeast Asia. Therefore, whether the Malaysian market can truly deliver as a new growth curve requires observing whether, after 2027, it can break away from the single gym scenario and build a localized wholesale distribution network.
In summary, driven by the B2B business, FitLife International still has growth momentum in the short term, but the key factor determining the company's long-term value lies in whether the three major incrementsB2C, marketing services, and overseas market expansioncan truly "break through." This is not only an extension of the business, but also a necessary major test for the company to move from "single-core drive" to "multi-dimensional growth," and the market is watching closely.
Related Articles

CNBM (03323): Ningxia Building Materials Group (600449.SH) reported a net profit attributable to shareholders of RMB 123 million for the first three quarters, down 44.32% year on year.

GRAND PHARMA (00512) proposes appointing Deloitte as the new auditor.

European molecular testing leader Qiagen (QGEN.US) accepts EQT acquisition offer: 46.50 per share, a 40.3% premium to its July share price.
CNBM (03323): Ningxia Building Materials Group (600449.SH) reported a net profit attributable to shareholders of RMB 123 million for the first three quarters, down 44.32% year on year.

GRAND PHARMA (00512) proposes appointing Deloitte as the new auditor.

European molecular testing leader Qiagen (QGEN.US) accepts EQT acquisition offer: 46.50 per share, a 40.3% premium to its July share price.






